LT97027A - Use of the i-rna in the pharmaceuticals for increasing of the amount of protein encoded by said rna in patient cells - Google Patents

Use of the i-rna in the pharmaceuticals for increasing of the amount of protein encoded by said rna in patient cells

Info

Publication number
LT97027A
LT97027A LT97-027A LT97027A LT97027A LT 97027 A LT97027 A LT 97027A LT 97027 A LT97027 A LT 97027A LT 97027 A LT97027 A LT 97027A
Authority
LT
Lithuania
Prior art keywords
rna
pharmaceuticals
increasing
amount
protein encoded
Prior art date
Application number
LT97-027A
Other languages
Lithuanian (lt)
Other versions
LT4475B (en
Inventor
Virmantas Stunžėnas
Original Assignee
Virmantas Stunžėnas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virmantas Stunžėnas filed Critical Virmantas Stunžėnas
Priority to LT97-027A priority Critical patent/LT4475B/en
Priority to JP53753298A priority patent/JP2001517215A/en
Priority to GB9918974A priority patent/GB2337462A/en
Priority to PCT/LT1998/000001 priority patent/WO1998037900A1/en
Priority to DE19882018T priority patent/DE19882018T1/en
Publication of LT97027A publication Critical patent/LT97027A/en
Publication of LT4475B publication Critical patent/LT4475B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LT97-027A 1997-02-28 1997-02-28 Use of the i-rna in the pharmaceuticals for increasing of the amount of protein encoded by said rna in patient cells LT4475B (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
LT97-027A LT4475B (en) 1997-02-28 1997-02-28 Use of the i-rna in the pharmaceuticals for increasing of the amount of protein encoded by said rna in patient cells
JP53753298A JP2001517215A (en) 1997-02-28 1998-02-24 Use of selected RNAs instead of proteins or for specific immune regulation in the production of bioactive substances
GB9918974A GB2337462A (en) 1997-02-28 1998-02-24 Use of the rna chosen instead of a protein in production of bioactive substances or for specific immunity control
PCT/LT1998/000001 WO1998037900A1 (en) 1997-02-28 1998-02-24 Use of the rna chosen instead of a protein in production of bioactive substances or for specific immunity control
DE19882018T DE19882018T1 (en) 1997-02-28 1998-02-24 Use of the selected RNA instead of a protein in the production of bioactive substances or for specific immunity control

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LT97-027A LT4475B (en) 1997-02-28 1997-02-28 Use of the i-rna in the pharmaceuticals for increasing of the amount of protein encoded by said rna in patient cells

Publications (2)

Publication Number Publication Date
LT97027A true LT97027A (en) 1998-09-25
LT4475B LT4475B (en) 1999-02-25

Family

ID=19721814

Family Applications (1)

Application Number Title Priority Date Filing Date
LT97-027A LT4475B (en) 1997-02-28 1997-02-28 Use of the i-rna in the pharmaceuticals for increasing of the amount of protein encoded by said rna in patient cells

Country Status (5)

Country Link
JP (1) JP2001517215A (en)
DE (1) DE19882018T1 (en)
GB (1) GB2337462A (en)
LT (1) LT4475B (en)
WO (1) WO1998037900A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2824411A1 (en) * 1978-06-03 1979-12-13 Boehringer Sohn Ingelheim ANTIVIRAL T-RNA PREPARATIONS
FR2471785A1 (en) * 1979-12-21 1981-06-26 Fabre Sa Pierre RIBOSOMAL RNA-BASED IMMUNOSTIMULANT PREPARATIONS AND PROCESS FOR THE PREPARATION OF RNA
FR2598619A1 (en) * 1986-05-16 1987-11-20 Mafitra Management Services In Antiviral medicament based on modified nucleic acid, and method for preparing it
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
CA2126686A1 (en) * 1991-12-24 1993-07-08 Mark D. Howell Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
CA2110946A1 (en) 1992-12-09 1994-06-10 Elazar Rabbani Induction of immunocompatibility by nucleic acid
IL112873A (en) * 1994-03-08 2005-03-20 Wyeth Corp Rapamycin-fkbp12 binding proteins, their isolation and their use

Also Published As

Publication number Publication date
WO1998037900A1 (en) 1998-09-03
GB9918974D0 (en) 1999-10-13
LT4475B (en) 1999-02-25
GB2337462A (en) 1999-11-24
DE19882018T1 (en) 2000-01-13
JP2001517215A (en) 2001-10-02

Similar Documents

Publication Publication Date Title
HK1033278A1 (en) Pharmaceutical preparation for use in anti-asthma therapy.
HK1041436A1 (en) Use of nicotinic acid derivatives for the treatment of dna damae in skin cells.
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
HK1019605A1 (en) Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
HUP0104296A3 (en) Cross-linked hyaluronic acids, uses thereof and biological substances containing them
HU9800075D0 (en) Nucleic acid construct for expressing active substances wich can be activated by proteases, and preparation and use
ZA985030B (en) Composition for use in personal care.
ID16283A (en) COMFORT USED IN PHARMACEUTICAL
HUP0001937A3 (en) Compounds, preparation and use for transferring nucleic acids into cells
AU3510200A (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
GB9603069D0 (en) Improvements in or relating to gene expression
HUP0104825A3 (en) Genes and proteins, and their use
HUP9900317A3 (en) Pharmaceutical composition useful for nucleic acid transfection, and use thereof
HUP0002329A3 (en) New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
EP1044216A4 (en) DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEINS, nNR7 AND nNR7-1
LT97027A (en) Use of the i-rna in the pharmaceuticals for increasing of the amount of protein encoded by said rna in patient cells
IT1279079B1 (en) VIBRATOR, IN PARTICULAR FOR DENTAL LABORATORY
AU1959200A (en) New utilization of alpha-hidroxy-propionic acid in medicine
AU1926699A (en) Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis
EP1007540A4 (en) Dna molecules encoding human nuclear receptor proteins
AU8105798A (en) Mammalian cell transduction for use in gene therapy
GB9726575D0 (en) Nucleic acid, polypeptides, assays, therapeutic methods and means
AU6206500A (en) Human proteins involved in detoxification
MXPA01007944A (en) Proteins related to neuronal regeneration and uses thereof.

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20020228